173 related articles for article (PubMed ID: 37684602)
21. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
22. CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma.
Wang X; Tang X; Gu J; Sun Z; Yang S; Mu Y; Guan M; Chen K; Liu W; Ruan H; Xu J
Cancer Med; 2023 Feb; 12(4):4521-4529. PubMed ID: 36082960
[TBL] [Abstract][Full Text] [Related]
23. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
Yamamoto N; Kinoshita T; Nohata N; Yoshino H; Itesako T; Fujimura L; Mitsuhashi A; Usui H; Enokida H; Nakagawa M; Shozu M; Seki N
Int J Oncol; 2013 Dec; 43(6):1855-63. PubMed ID: 24141696
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
25. miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.
Chen X; Jiang Y; Huang Z; Li D; Chen X; Cao M; Meng Q; Pang H; Sun L; Zhao Y; Cai L
Sci Rep; 2016 Jan; 6():19455. PubMed ID: 26781643
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
[TBL] [Abstract][Full Text] [Related]
27. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
28. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA‑29a enhances cisplatin sensitivity in non‑small cell lung cancer through the regulation of REV3L.
Chen X; Zhu H; Ye W; Cui Y; Chen M
Mol Med Rep; 2019 Feb; 19(2):831-840. PubMed ID: 30535450
[TBL] [Abstract][Full Text] [Related]
30. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
Huang RS; Zheng YL; Zhao J; Chun X
Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
Cheng R; Lu C; Zhang G; Zhang G; Zhao G
Oncol Rep; 2017 Apr; 37(4):2129-2136. PubMed ID: 28350100
[TBL] [Abstract][Full Text] [Related]
32. miR-29a-3p inhibits the malignant characteristics of non-small cell lung cancer cells by reducing the activity of the Wnt/β-catenin signaling pathway.
Zhang K; Han X; Hu W; Su C; He B
Oncol Lett; 2022 Oct; 24(4):379. PubMed ID: 36238844
[TBL] [Abstract][Full Text] [Related]
33.
Chuang PC; Chen PT; Wang CC; Su WH; Chen YH; Huang EY
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628336
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1.
Hu Z; Cui Y; Zhou Y; Zhou K; Qiao X; Li C; Wang S
Onco Targets Ther; 2016; 9():6999-7009. PubMed ID: 27895492
[TBL] [Abstract][Full Text] [Related]
35. MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G₁/S transition and apoptosis by targeting p21(WAF1/CIP1).
Wang H; Zhu LJ; Yang YC; Wang ZX; Wang R
Br J Cancer; 2014 Jul; 111(2):339-54. PubMed ID: 24921914
[TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein.
Kolla V; Gonzales LW; Bailey NA; Wang P; Angampalli S; Godinez MH; Madesh M; Ballard PL
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L1019-30. PubMed ID: 19329538
[TBL] [Abstract][Full Text] [Related]
37. Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.
Yu N; Yong S; Kim HK; Choi YL; Jung Y; Kim D; Seo J; Lee YE; Baek D; Lee J; Lee S; Lee JE; Kim J; Kim J; Lee S
Mol Oncol; 2019 Jun; 13(6):1356-1368. PubMed ID: 30913346
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
Cao L; Zhou X; Ding X; Gao D
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328193
[TBL] [Abstract][Full Text] [Related]
39. Roles of H19/miR-29a-3p/COL1A1 axis in COE-induced lung cancer.
Zhang H; Li X; Jia M; Ji J; Wu Z; Chen X; Yu D; Zheng Y; Zhao Y
Environ Pollut; 2022 Nov; 313():120194. PubMed ID: 36150622
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
